Cardiovascular Safety of Dipeptidyl-Peptidase IV Inhibitors: A Meta-Analysis of Placebo-Controlled Randomized Trials

被引：0
|
作者：
Islam Y. Elgendy
Ahmed N. Mahmoud
Amr F. Barakat
Akram Y. Elgendy
Marwan Saad
Ahmed Abuzaid
Siddarth A. Wayangankar
Anthony A. Bavry
机构：
[1] University of Florida,Division of Cardiovascular Medicine, Department of Medicine
[2] Cleveland Clinic,Department of Medicine
[3] University of Arkansas,Department of Medicine
[4] Jefferson University Hospital/Christiana Care Health System,Division of Cardiovascular Medicine
[5] North Florida/South Georgia Veterans Health System,undefined
来源：
American Journal of Cardiovascular Drugs | 2017年 / 17卷
关键词：
Heart Failure; Ischemic Stroke; Cardiovascular Outcome; Sitagliptin; Vildagliptin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：143 / 155
页数：12
相关论文
共 50 条
  • [1] Cardiovascular Safety of Dipeptidyl-Peptidase IV Inhibitors: A Meta-Analysis of Placebo-Controlled Randomized Trials
    Elgendy, Islam Y.
    Mahmoud, Ahmed N.
    Barakat, Amr F.
    Elgendy, Akram Y.
    Saad, Marwan
    Abuzaid, Ahmed
    Wayangankar, Siddarth A.
    Bavry, Anthony A.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2017, 17 (02) : 143 - 155
  • [2] Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials
    Monami, Matteo
    Dicembrini, Ilaria
    Martelli, Daniele
    Mannucci, Edoardo
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 : 57 - 64
  • [3] Cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of cardiovascular outcome trials
    Patoulias, Dimitrios Ioannis
    Boulmpou, Aristi
    Teperikidis, Eleftherios
    Katsimardou, Alexandra
    Siskos, Fotios
    Doumas, Michael
    Papadopoulos, Christodoulos E.
    Vassilikos, Vassilios
    WORLD JOURNAL OF CARDIOLOGY, 2021, 13 (10): : 585 - 592
  • [4] Effects on Lipid Profile of Dipeptidyl Peptidase 4 Inhibitors, Pioglitazone, Acarbose, and Sulfonylureas: Meta-analysis of Placebo-Controlled Trials
    Matteo Monami
    Valentina Vitale
    Maria Luisa Ambrosio
    Nadia Bartoli
    Giulia Toffanello
    Benedetta Ragghianti
    Francesca Monami
    Niccolò Marchionni
    Edoardo Mannucci
    Advances in Therapy, 2012, 29 : 736 - 746
  • [5] Effects on Lipid Profile of Dipeptidyl Peptidase 4 Inhibitors, Pioglitazone, Acarbose, and Sulfonylureas: Meta-analysis of Placebo-Controlled Trials
    Monami, Matteo
    Vitale, Valentina
    Ambrosio, Maria Luisa
    Bartoli, Nadia
    Toffanello, Giulia
    Ragghianti, Benedetta
    Monami, Francesca
    Marchionni, Niccolo
    Mannucci, Edoardo
    ADVANCES IN THERAPY, 2012, 29 (09) : 736 - 746
  • [6] Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials
    Monami, M.
    Ahren, B.
    Dicembrini, I.
    Mannucci, E.
    DIABETES OBESITY & METABOLISM, 2013, 15 (02): : 112 - 120
  • [7] Cardiovascular and non-cardiovascular safety of dipeptidyl peptidase-4 inhibition: a meta-analysis of randomized controlled cardiovascular outcome trials
    Abbas, A. S.
    Dehbi, H. -M.
    Ray, K. K.
    DIABETES OBESITY & METABOLISM, 2016, 18 (03): : 295 - 299
  • [8] Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials
    Giovanni Antonio Silverii
    Ilaria Dicembrini
    Besmir Nreu
    Chiara Montereggi
    Edoardo Mannucci
    Matteo Monami
    Endocrine, 2020, 69 : 504 - 507
  • [9] Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials
    Silverii, Giovanni Antonio
    Dicembrini, Ilaria
    Nreu, Besmir
    Montereggi, Chiara
    Mannucci, Edoardo
    Monami, Matteo
    ENDOCRINE, 2020, 69 (03) : 504 - 507
  • [10] Bisphosphonate and Adverse Cardiovascular Events: Meta-Analysis of Randomized Placebo-Controlled Trials
    Kim, Dae Hyun
    Rogers, James R.
    Fulchino, Lisa A.
    Solomon, Daniel H.
    Kim, Seoyoung C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 446 - 446
12345